Deciphex 🇮🇪

Series C

AI-powered digital pathology platform enhancing diagnostics and drug development with image capture and AI-driven analysis.

About Deciphex

Deciphex offers an AI-powered digital platform that enhances the efficiency of pathology processes, including high-quality image capture and AI-driven image analysis, to support accurate diagnostics and drug development. Their technology integrates global networks of pathologists and streamlines regulated research workflows, improving drug safety and accelerating the end-to-end drug development process.

Deciphex is a Ireland-based company founded in 2017, now around 168 people. It has raised $82.2M in disclosed funding. FundFinder classes it as AI & ML.

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Deciphex? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series C · Oct 2025

Investors

Act Venture Capital

Act Venture Capital — Act are a UK/Ireland seed fund investing in a number if different areas, primarily in B2B SaaS and Fintech. · cheques £100k – £10M

Raising your own round? See which European funds fit →